Voluntary Recall of Viapro 375mg Capsules Due To A Potentially Harmful Analog Of Sildenafil

The FDA, in conjunction with EG Labs LLC has issued a voluntary recall of the popular erectile dysfunction drug, Viapro.  The MedWatch annoucment is as follows:

EG Labs, LLC, notified consumers and healthcare professionals not to buy or use Viapro 375mg Capsules because one lot of the product was found to contain a potentially harmful undeclared ingredient, thio-methisosildenafil, an analog of sildenafil, a FDA approved product used to treat erectile dysfunction in men to enhance sexual performance. The undeclared ingredient may interact with nitrates found in some prescription drugs (such as nitroglycerin) and can lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take products containing nitrates. Consumers who have this product should discontinue using it and consult their healthcare professional if they experience any problems that may be related to taking Viapro.

Read the entire 2008 MedWatch Safety summary, including a link to the manufacturer’s Press Release regarding this issue at:

For further information on this recall or to speak to a defective drug attorney, call (856) 833-0600 in NJ or (215) 567-2380 in PA, or fill out the form on the left side of the page.

Leave a Reply

Your email address will not be published.